Female sex hormones and symptoms of obstructive sleep apnea in European women of a population-based cohort.

<h4>Background</h4>The prevalence of obstructive sleep apnea is higher in women after menopause. This is suggested to be a result of an altered sex hormone balance but has so far not been confirmed in a population-based study.<h4>Objective</h4>To investigate whether serum con...

Full description

Bibliographic Details
Main Authors: Erla S Sigurðardóttir, Thorarinn Gislason, Bryndis Benediktsdottir, Steinar Hustad, Payam Dadvand, Pascal Demoly, Karl A Franklin, Joachim Heinrich, Mathias Holm, Diana A van der Plaat, Rain Jõgi, Benedicte Leynaert, Eva Lindberg, Jesus Martinez-Moratalla, Leire Sainz De Aja, Giancarlo Pesce, Isabelle Pin, Chantal Raherison, Antonio Pereira-Vega, Francisco Gómez Real, Kai Triebner
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0269569
_version_ 1811217406049124352
author Erla S Sigurðardóttir
Thorarinn Gislason
Bryndis Benediktsdottir
Steinar Hustad
Payam Dadvand
Pascal Demoly
Karl A Franklin
Joachim Heinrich
Mathias Holm
Diana A van der Plaat
Rain Jõgi
Benedicte Leynaert
Eva Lindberg
Jesus Martinez-Moratalla
Leire Sainz De Aja
Giancarlo Pesce
Isabelle Pin
Chantal Raherison
Antonio Pereira-Vega
Francisco Gómez Real
Kai Triebner
author_facet Erla S Sigurðardóttir
Thorarinn Gislason
Bryndis Benediktsdottir
Steinar Hustad
Payam Dadvand
Pascal Demoly
Karl A Franklin
Joachim Heinrich
Mathias Holm
Diana A van der Plaat
Rain Jõgi
Benedicte Leynaert
Eva Lindberg
Jesus Martinez-Moratalla
Leire Sainz De Aja
Giancarlo Pesce
Isabelle Pin
Chantal Raherison
Antonio Pereira-Vega
Francisco Gómez Real
Kai Triebner
author_sort Erla S Sigurðardóttir
collection DOAJ
description <h4>Background</h4>The prevalence of obstructive sleep apnea is higher in women after menopause. This is suggested to be a result of an altered sex hormone balance but has so far not been confirmed in a population-based study.<h4>Objective</h4>To investigate whether serum concentration of estrogens and progesterone are associated with the prevalence of sleep apnea symptoms in middle-aged women of the general population.<h4>Methods</h4>We analyzed data from 774 women (40-67 years) from 15 study centers in seven countries participating in the second follow-up of the European Community Respiratory Health Survey (2010-2012). Multiple logistic regression models were fitted with self-reported symptoms of sleep apnea as outcomes and serum concentrations of various estrogens and progesterone as predictors. All analyses were adjusted for relevant covariates including age, BMI, education, study center, smoking habits, and reproductive age.<h4>Results</h4>Among all included women, a doubling of serum concentrations of estrone and progesterone was associated with 19% respectively 9% decreased odds of snoring. Among snorers, a doubling of the concentrations of 17β-estradiol, estrone and estrone 3-sulfate was associated with 18%, 23% and 17% decreased odds of breathing irregularly, and a doubling of the progesterone concentration was further associated with 12% decreased odds of waking up suddenly with a chocking sensation. Other evaluated associations were not statistically significant.<h4>Conclusions</h4>Middle-aged women with low serum estrogen and progesterone levels are more likely to snore and report symptoms of obstructive sleep apnea.
first_indexed 2024-04-12T06:54:35Z
format Article
id doaj.art-2c96cba80ba045349659184b59d35580
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T06:54:35Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-2c96cba80ba045349659184b59d355802022-12-22T03:43:11ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01176e026956910.1371/journal.pone.0269569Female sex hormones and symptoms of obstructive sleep apnea in European women of a population-based cohort.Erla S SigurðardóttirThorarinn GislasonBryndis BenediktsdottirSteinar HustadPayam DadvandPascal DemolyKarl A FranklinJoachim HeinrichMathias HolmDiana A van der PlaatRain JõgiBenedicte LeynaertEva LindbergJesus Martinez-MoratallaLeire Sainz De AjaGiancarlo PesceIsabelle PinChantal RaherisonAntonio Pereira-VegaFrancisco Gómez RealKai Triebner<h4>Background</h4>The prevalence of obstructive sleep apnea is higher in women after menopause. This is suggested to be a result of an altered sex hormone balance but has so far not been confirmed in a population-based study.<h4>Objective</h4>To investigate whether serum concentration of estrogens and progesterone are associated with the prevalence of sleep apnea symptoms in middle-aged women of the general population.<h4>Methods</h4>We analyzed data from 774 women (40-67 years) from 15 study centers in seven countries participating in the second follow-up of the European Community Respiratory Health Survey (2010-2012). Multiple logistic regression models were fitted with self-reported symptoms of sleep apnea as outcomes and serum concentrations of various estrogens and progesterone as predictors. All analyses were adjusted for relevant covariates including age, BMI, education, study center, smoking habits, and reproductive age.<h4>Results</h4>Among all included women, a doubling of serum concentrations of estrone and progesterone was associated with 19% respectively 9% decreased odds of snoring. Among snorers, a doubling of the concentrations of 17β-estradiol, estrone and estrone 3-sulfate was associated with 18%, 23% and 17% decreased odds of breathing irregularly, and a doubling of the progesterone concentration was further associated with 12% decreased odds of waking up suddenly with a chocking sensation. Other evaluated associations were not statistically significant.<h4>Conclusions</h4>Middle-aged women with low serum estrogen and progesterone levels are more likely to snore and report symptoms of obstructive sleep apnea.https://doi.org/10.1371/journal.pone.0269569
spellingShingle Erla S Sigurðardóttir
Thorarinn Gislason
Bryndis Benediktsdottir
Steinar Hustad
Payam Dadvand
Pascal Demoly
Karl A Franklin
Joachim Heinrich
Mathias Holm
Diana A van der Plaat
Rain Jõgi
Benedicte Leynaert
Eva Lindberg
Jesus Martinez-Moratalla
Leire Sainz De Aja
Giancarlo Pesce
Isabelle Pin
Chantal Raherison
Antonio Pereira-Vega
Francisco Gómez Real
Kai Triebner
Female sex hormones and symptoms of obstructive sleep apnea in European women of a population-based cohort.
PLoS ONE
title Female sex hormones and symptoms of obstructive sleep apnea in European women of a population-based cohort.
title_full Female sex hormones and symptoms of obstructive sleep apnea in European women of a population-based cohort.
title_fullStr Female sex hormones and symptoms of obstructive sleep apnea in European women of a population-based cohort.
title_full_unstemmed Female sex hormones and symptoms of obstructive sleep apnea in European women of a population-based cohort.
title_short Female sex hormones and symptoms of obstructive sleep apnea in European women of a population-based cohort.
title_sort female sex hormones and symptoms of obstructive sleep apnea in european women of a population based cohort
url https://doi.org/10.1371/journal.pone.0269569
work_keys_str_mv AT erlassigurðardottir femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT thorarinngislason femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT bryndisbenediktsdottir femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT steinarhustad femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT payamdadvand femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT pascaldemoly femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT karlafranklin femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT joachimheinrich femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT mathiasholm femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT dianaavanderplaat femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT rainjogi femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT benedicteleynaert femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT evalindberg femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT jesusmartinezmoratalla femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT leiresainzdeaja femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT giancarlopesce femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT isabellepin femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT chantalraherison femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT antoniopereiravega femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT franciscogomezreal femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort
AT kaitriebner femalesexhormonesandsymptomsofobstructivesleepapneaineuropeanwomenofapopulationbasedcohort